Literature DB >> 12719987

Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.

S Aisenbrey1, B A Lafaut, S Reynders, P Szurman, S Grisanti, C Vanden Broecke, P Walter, K U Bartz-Schmidt.   

Abstract

PURPOSE: To analyze the histopathology of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.
METHODS: A retrospective non-case-matched comparative histopathologic study. The histoarchitecture of nine surgically removed subretinal specimens from nine patients that had undergone external beam radiotherapy for exudative age-related macular degeneration was studied. Seven patients had received 20 Gy in 10 fractions and two 15 Gy in 5 fractions with an average time interval between radiotherapy and surgical extraction of 14 months (range 3-28). A consecutive series of classic, mixed and occult choroidal neovascular membranes served as controls.
RESULTS: Clinical findings. Radiation-associated choroidal neovasculopathy was angiographically suspected in four patients: a coarse net of vessels on fluorescein angiography developing at the border of previously irradiated choroidal neovascularization was observed in three patients; blebs at the margin of a plaque on indocyanine green angiography were observed in two patients. Pathological findings. Diffuse drusen as well as intra-Bruch's fibrovascular tissue was found in all irradiated specimens. In four specimens an edematous vascularized layer was seen between diffuse drusen and normal-appearing intra-Bruch's fibrovascular tissue. This lesion was not found in the control specimens. A particular correlation for the bleb lesion was not recognized.
CONCLUSION: The appearance of an edematous subretinal pigment epithelial vascularized layer between diffuse drusen and normal-appearing fibrovascular tissue in four of nine irradiated membranes may be secondary to previous irradiation. It may correlate with the unusual exudative manifestations observed after external beam radiotherapy.

Entities:  

Mesh:

Year:  2003        PMID: 12719987     DOI: 10.1007/s00417-003-0634-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  38 in total

Review 1.  Radiotherapy for choroidal neovascularisation of age-related macular degeneration: a fresh perspective.

Authors:  U Chakravarthy
Journal:  Eye (Lond)       Date:  2000-04       Impact factor: 3.775

2.  A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration.

Authors: 
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

3.  Radiation-associated choroidal neovasculopathy.

Authors:  R F Spaide; A Leys; B Herrmann-Delemazure; P Stalmans; M Tittl; L A Yannuzzi; K M Burke; Y L Fisher; K B Freund; D R Guyer; J S Slakter; J A Sorenson
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

4.  Teletherapy for subfoveal choroidal neovascularisation of age-related macular degeneration: results of follow up in a non-randomised study.

Authors:  P M Hart; U Chakravarthy; G MacKenzie; D B Archer; R F Houston
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

5.  A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation.

Authors:  G J Bergink; C B Hoyng; R W van der Maazen; J R Vingerling; W A van Daal; A F Deutman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-05       Impact factor: 3.117

6.  Radiotherapy of exudative age-related macular degeneration; a clinical and pathologic study.

Authors:  A C Lambooij; R W Kuijpers; C M Mooy; M Kliffen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-07       Impact factor: 3.117

7.  Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration.

Authors:  C J Flaxel; E J Friedrichsen; J O Smith; S C Oeinck; P A Blacharski; C A Garcia; H H Chu
Journal:  Eye (Lond)       Date:  2000-04       Impact factor: 3.775

8.  External beam radiation therapy for choroidal neovascularization.

Authors:  R F Spaide; D R Guyer; B McCormick; L A Yannuzzi; K Burke; M Mendelsohn; A Haas; J S Slakter; J A Sorenson; Y L Fisher; D Abramson
Journal:  Ophthalmology       Date:  1998-01       Impact factor: 12.079

9.  An alternative and more cost effective method of delivery of radiotherapy in age related macular degeneration.

Authors:  A J Churchill; W A Franks; D V Ash
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

10.  Clinicopathologic features of surgically excised choroidal neovascular membranes.

Authors:  H E Grossniklaus; A K Hutchinson; A Capone; J Woolfson; H M Lambert
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

View more
  2 in total

1.  StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.

Authors:  James E Neffendorf; Riti Desai; Yanzhong Wang; Joanna Kelly; Caroline Murphy; Barnaby C Reeves; Usha Chakravarthy; Sarah Wordsworth; Cornelius Lewis; Janet Peacock; Shahir Uddin; Joe M O'Sullivan; Timothy L Jackson
Journal:  Trials       Date:  2016-11-24       Impact factor: 2.279

2.  In vitro evaluation of simulated stereotactic radiotherapy for wet age-related macular degeneration on three different cell lines.

Authors:  Efstathios Vounotrypidis; Anna Hillenmayer; Christian M Wertheimer; Alexis Athanasiou; Jakob Siedlecki; Michael Orth; Andreas Ohlmann; Siegfried G Priglinger; Armin Wolf
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.